Healius (FRA:PGZ) FFO


FRA:PGZ Healius Ltd FRA:PGZ
54 GF Score
Price €0.21
GF Value €0.57
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Healius FFO?

FFO (Funds from operations) only applies to REITs.

FRA:PGZ
54GF Score
Healius Ltd FRA:PGZ
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Healius (FRA:PGZ) Overvalued in 2026?

Based on GuruFocus' analysis, Healius stock appears to be undervalued. The current stock price of €0.21 is trading 63.2% below its estimated GF Value™ of €0.57. GuruFocus considers Healius to be Possible Value Trap.

Key valuation signals for FRA:PGZ:

  • FFO:
  • GF Value™: €0.57 vs. price of €0.21 (63.2% below fair value)
  • GF Score™: 54/100 with 7 warning signs

No single metric tells the full story. See the FRA:PGZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Healius Business Description

Other Exchanges HLS:Australia
Address 161 Castlereagh Street, Level 22, Sydney, NSW, AUS, 2000
Healius is Australia's second-largest pathology provider. Pathology revenue is almost entirely earned via the public health Medicare system and makes up the majority of Healius' group revenue. A small portion comes from its clinical testing business, Agilex.
54GF Score

Get the complete analysis for FRA:PGZ

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.21
Price
€0.57
GF Value